IS4382A - Ný peptíð með ónæmisbreytandi áhrif - Google Patents

Ný peptíð með ónæmisbreytandi áhrif

Info

Publication number
IS4382A
IS4382A IS4382A IS4382A IS4382A IS 4382 A IS4382 A IS 4382A IS 4382 A IS4382 A IS 4382A IS 4382 A IS4382 A IS 4382A IS 4382 A IS4382 A IS 4382A
Authority
IS
Iceland
Prior art keywords
new peptide
immunogenic effect
immunogenic
effect
peptide
Prior art date
Application number
IS4382A
Other languages
English (en)
Inventor
Bergstrand Håkan
Eriksson Tomas
Lindvall Magnus
Särnstrand Bengt
Original Assignee
Astra Aktiebolag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Aktiebolag filed Critical Astra Aktiebolag
Publication of IS4382A publication Critical patent/IS4382A/is

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Immunology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
IS4382A 1995-03-24 1996-11-08 Ný peptíð með ónæmisbreytandi áhrif IS4382A (is)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9501067A SE9501067D0 (sv) 1995-03-24 1995-03-24 New peptides
PCT/SE1996/000365 WO1996030397A1 (en) 1995-03-24 1996-03-22 New peptides with immunomodulatory effects

Publications (1)

Publication Number Publication Date
IS4382A true IS4382A (is) 1996-11-08

Family

ID=20397676

Family Applications (1)

Application Number Title Priority Date Filing Date
IS4382A IS4382A (is) 1995-03-24 1996-11-08 Ný peptíð með ónæmisbreytandi áhrif

Country Status (20)

Country Link
US (1) US6228373B1 (is)
EP (1) EP0785945A1 (is)
JP (1) JPH10501003A (is)
AR (1) AR002724A1 (is)
AU (1) AU5166296A (is)
BR (1) BR9605890A (is)
CA (1) CA2189656A1 (is)
CZ (1) CZ344096A3 (is)
EE (1) EE9600208A (is)
HU (1) HUP9603537A3 (is)
IL (1) IL117615A0 (is)
IS (1) IS4382A (is)
NO (1) NO964959D0 (is)
NZ (1) NZ304468A (is)
PL (1) PL317348A1 (is)
SE (1) SE9501067D0 (is)
SK (1) SK150196A3 (is)
TR (1) TR199600932T1 (is)
WO (1) WO1996030397A1 (is)
ZA (1) ZA962345B (is)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0923604A1 (en) * 1996-04-12 1999-06-23 Astra Aktiebolag Cysteine-containing or methioine-containing peptides with immunomodulatory effects
SE9603465D0 (sv) * 1996-09-23 1996-09-23 Astra Ab New compounds
AU9655698A (en) * 1997-10-10 1999-05-03 Astra Aktiebolag Synthetic genes with immunomodulatory effects
RU2144374C1 (ru) * 1998-11-23 2000-01-20 Закрытое акционерное общество "ВАМ" Способ получения композита окисленного глутатиона с cis-диаминодихлорплатиной и фармацевтических композиций на его основе, регулирующих метаболизм, пролиферацию, дифференцировку и механизмы апоптоза нормальных и трансформированных клеток
EP1140227B1 (de) * 1998-12-21 2003-10-01 IVF Hartmann AG Infektionsschutz-tampon
US7265208B2 (en) * 2001-05-01 2007-09-04 The Regents Of The University Of California Fusion molecules and treatment of IgE-mediated allergic diseases
FR2872042B1 (fr) * 2004-06-29 2006-09-15 Soc Extraction Principes Actif Utilisation d'un dipeptide dimerise en tant qu'agent actif dans ou pour la preparation une composition cosmetique et/ou dermatologique
GB2442408B (en) 2005-04-25 2010-06-30 Cadila Pharmaceuticals Ltd Mycobacterium W as an adjuvant
GB0524884D0 (en) 2005-12-06 2006-01-11 Syngenta Ltd Improvements in or relating to organic compounds
KR101430627B1 (ko) 2008-05-13 2014-08-14 유니버시티 오브 캔사스 금속 추출 펩타이드(ｍａｐ) 태그 및 관련된 방법
WO2013181461A2 (en) 2012-06-01 2013-12-05 University Of Kansas Metal abstraction peptide with superoxide dismutase activity

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4585755A (en) 1985-04-29 1986-04-29 Merck & Co., Inc. Cyclic and bridged cyclic somatostatin analogs useful as local anti-inflammatory agents
US4822606A (en) * 1986-04-07 1989-04-18 Duke University Immunosuppressive synthetic peptides and analogs thereof based on retroviral envelope sequences
AU1366088A (en) 1987-01-28 1988-08-24 Ortho Pharmaceutical Corporation Immunosuppressive peptides and methods of use
FR2622700B1 (fr) * 1987-10-30 1993-08-13 Aderegem Proteine et ses fragments representant l'expression specifique du gene ps2 des cancers du sein, anticorps obtenus a partir de ladite proteine et/ou de ses fragments, leurs applications a la detection et au diagnostic de cancers du sein
WO1989010935A1 (en) 1988-05-09 1989-11-16 Abbott Laboratories Atrial peptide derivatives
US5223485A (en) 1989-01-31 1993-06-29 Abbott Laboratories Anaphylatoxin-receptor ligands
IL98310A (en) * 1990-06-08 1996-08-04 Astra Ab Medicinal preparations containing a history of cystine
KR100274321B1 (ko) 1990-09-11 2000-12-15 스미드 이. 그레이엄 데르마토파고이디즈(집 먼지 진드기)의 알레르기 항원의 클로닝 및 서열결정
WO1993000108A1 (en) 1991-06-28 1993-01-07 Corvas International, Inc. Novel inhibitors of platelet aggregation
WO1993008279A1 (en) 1991-10-16 1993-04-29 Immulogic Pharmaceutical Corporation T cell epitopes of the major allergens from dermatophagoides (house dust mite)
NZ263050A (en) 1993-03-05 1997-11-24 Cytel Corp Compositions of immunogenic peptides with hla-a2.1 binding motifs
IL106214A (en) 1993-07-01 1998-12-06 Yeda Res & Dev Thf-gamma2 analogs and pharmaceutical compositions comprising them
JPH07215996A (ja) 1994-01-31 1995-08-15 Torii Yakuhin Kk ダニアレルゲンのｂ細胞エピトープ
RU2218348C2 (ru) 1994-07-05 2003-12-10 Стено Рисерч Груп А/С Полипептид с il-10 подобными свойствами (варианты), конъюгат полипептида, фармацевтическая композиция, способ модуляции иммунного ответа у млекопитающего
SE9403526D0 (sv) 1994-10-14 1994-10-14 Astra Ab New Peptides

Also Published As

Publication number Publication date
ZA962345B (en) 1996-09-25
EP0785945A1 (en) 1997-07-30
WO1996030397A1 (en) 1996-10-03
NO964959L (no) 1996-11-21
HUP9603537A3 (en) 1998-03-02
HU9603537D0 (en) 1997-02-28
NO964959D0 (no) 1996-11-21
TR199600932T1 (tr) 1997-03-21
AU5166296A (en) 1996-10-16
AR002724A1 (es) 1998-04-29
PL317348A1 (en) 1997-04-01
CZ344096A3 (en) 1997-05-14
CA2189656A1 (en) 1996-10-03
US6228373B1 (en) 2001-05-08
BR9605890A (pt) 1997-09-23
NZ304468A (en) 1999-02-25
SK150196A3 (en) 1997-06-04
IL117615A0 (en) 1996-07-23
HUP9603537A2 (en) 1997-08-28
SE9501067D0 (sv) 1995-03-24
JPH10501003A (ja) 1998-01-27
EE9600208A (et) 1997-06-16

Similar Documents

Publication Publication Date Title
IT1277331B1 (it) Seggiolone a chiusura migliorata
DE69637459D1 (de) Intranasaler Medikator
DE69606663D1 (de) Förderer
DE69604763D1 (de) Förderer
DK0858351T3 (da) Ikke-tilstoppende kanyle
DE69605168D1 (de) Einspritzventil
IS4115A (is) Ný peptíð
NO976058L (no) Rekombinant mistellectin
FI970168A (fi) Peptidejä
IS4382A (is) Ný peptíð með ónæmisbreytandi áhrif
DE69625992D1 (de) Einspritzventil
DE69600080D1 (de) Verbindungsanordnung
DE59602366D1 (de) Einspritzdüse
BR9606756A (pt) Peptídeo
NO981052D0 (no) Peptidderivater
NO981051D0 (no) Peptidderivater
DK0866800T3 (da) Antineoplastiske peptider
NO982280L (no) Cyklopeptider
DE59606137D1 (de) Einspritzeinrichtung
BR9611835A (pt) Fluorbutenil aminocarboxilatos
SE9504467D0 (sv) Peptide
BR1100812A (pt) Peptìdeo
KR960033595U (ko) 공기 주입기
DE69601745D1 (de) Förderer
KR970004604U (ko) 개선된 형상구조